Calfactant
| Clinical data | |
|---|---|
| Trade names | Infasurf |
| Pregnancy category |
|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
  (what is this?) (verify) | |
Calfactant, also known as Infasurf,[1] is an intratracheal suspension derived from the natural surfactant in calf lungs. It is used in premature infants with lung surfactant deficiency that causes infant respiratory distress syndrome (IRDS).[2]
Mechanism of action
[edit]Lung surfactant is essential for effective ventilation as it modifies alveolar surface tension.[3] IRDS is caused by a lung surfactant deficiency. Calfactant serves as a substitute for the natural surfactant.[2]
References
[edit]- ↑ "Infasurf". Archived from the original on 2011-12-09. Retrieved 2011-12-16.
- 1 2 Drugs.com: "Calfactant". Drugs.com.
- ↑ Schurch S, Lee M, Gehr P (1992). "Pulmonary surfactant: Surface properties and function of alveolar and airway surfactant". Pure and Applied Chemistry. 64 (11): 1745–1750. doi:10.1351/pac199264111745. S2CID 97007574.
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by adding missing information. |